EverPoint Asset Management, LLC historic quarter change: Foreign Stocks, Added
In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 9 quarters from 2014-06-30 to 2016-09-30, EverPoint Asset Management, LLC opened 22 positions, added to 14, reduced 13 and sold out of 31.
- Q4 2015: Stock SGMOQ; Country of operation United States; Class COM; Shares before 1,050,000.
- Q4 2015: Stock TEVA; Country of operation —; Class ADR; Shares before 390,000.
- Q3 2015: Stock TEVA; Country of operation —; Class ADR; Shares before 150,000.
- Q3 2015: Stock SNN; Country of operation —; Class SPDN ADR NEW; Shares before 125,000.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1603464), 9 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2014-06-30.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q4 2015 | SGMOQ
SANGAMO BIOSCIENCES INC | United States | COM | 1,050,000 | 1,900,000 | +850,000 | $5,922,000 | $17,347,000 | +$11,425,000 | 2016-02-16 |
|---|
| Q4 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 390,000 | 450,000 | +60,000 | $22,019,000 | $29,538,000 | +$7,519,000 | 2016-02-16 |
|---|
| Q3 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 150,000 | 390,000 | +240,000 | $8,865,000 | $22,019,000 | +$13,154,000 | 2015-11-16 |
|---|
| Q3 2015 | SNN
SMITH & NEPHEW PLC | | SPDN ADR NEW | 125,000 | 200,000 | +75,000 | $4,244,000 | $7,000,000 | +$2,756,000 | 2015-11-16 |
|---|
| Q1 2015 | VNET
21VIANET GROUP INC | | SPONSORED ADR | 159,100 | 400,000 | +240,900 | $2,461,000 | $7,064,000 | +$4,603,000 | 2015-05-15 |
|---|
| Q1 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 490,000 | 500,000 | +10,000 | $28,180,000 | $31,150,000 | +$2,970,000 | 2015-05-15 |
|---|
| Q4 2014 | BIDU
BAIDU INC | | SPON ADR REP A | 55,000 | 202,279 | +147,279 | $12,003,000 | $46,114,000 | +$34,111,000 | 2015-02-17 |
|---|
| Q4 2014 | SGMOQ
SANGAMO BIOSCIENCES INC | United States | COM | 800,000 | 1,100,000 | +300,000 | $8,628,000 | $16,731,000 | +$8,103,000 | 2015-02-17 |
|---|
| Q4 2014 | SNN
SMITH & NEPHEW PLC | | SPDN ADR NEW | 75,000 | 215,000 | +140,000 | $6,314,000 | $7,899,000 | +$1,585,000 | 2015-02-17 |
|---|
| Q4 2014 | JD
JD COM INC | | SPON ADR CL A | 336,037 | 407,374 | +71,337 | $8,676,000 | $9,427,000 | +$751,000 | 2015-02-17 |
|---|
| Q3 2014 | JKS
JINKOSOLAR HLDG CO LTD | | SPONSORED ADR | 54,000 | 215,268 | +161,268 | $1,629,000 | $5,918,000 | +$4,289,000 | 2014-11-14 |
|---|
| Q3 2014 | NVS
NOVARTIS A G | | SPONSORED ADR | 75,000 | 110,000 | +35,000 | $6,790,000 | $10,354,000 | +$3,564,000 | 2014-11-14 |
|---|
| Q3 2014 | SNN
SMITH & NEPHEW PLC | | SPDN ADR NEW | 50,000 | 75,000 | +25,000 | $4,464,000 | $6,314,000 | +$1,850,000 | 2014-11-14 |
|---|
| Q3 2014 | SGMOQ
SANGAMO BIOSCIENCES INC | United States | COM | 625,000 | 800,000 | +175,000 | $9,544,000 | $8,628,000 | -$916,000 | 2014-11-14 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |